Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Effects of extended-release naltrexone on the brain response to drug-related stimuli in patients with opioid use disorder.

Shi Z, Wang AL, Jagannathan K, Fairchild VP, O'Brien CP, Childress AR, Langleben DD.

J Psychiatry Neurosci. 2018 Jul;43(4):254-261.

2.

Emotional salience of the image component facilitates recall of the text of cigarette warning labels.

Wang AL, Shi Z, Fairchild VP, Aronowitz CA, Langleben DD.

Eur J Public Health. 2018 Apr 26. doi: 10.1093/eurpub/cky059. [Epub ahead of print]

PMID:
29718188
3.

Effects of extended-release naltrexone on the brain response to drug-related stimuli in patients with opioid use disorder.

Shi Z, Wang AL, Jagannathan K, Fairchild VP, O'Brien CP, Childress AR, Langleben DD.

J Psychiatry Neurosci. 2018 Feb 23;43(3):170036. doi: 10.1503/jpn.170036. [Epub ahead of print]

PMID:
29485031
4.

Sustained opioid antagonism modulates striatal sensitivity to baby schema in opioid use disorder.

Wang AL, Lowen SB, Elman I, Shi Z, Fairchild VP, Bouril A, Gur RC, Langleben DD.

J Subst Abuse Treat. 2018 Feb;85:70-77. doi: 10.1016/j.jsat.2017.10.007. Epub 2017 Oct 18.

5.

Increased cocaine and amphetamine-regulated transcript cord blood levels in the newborns exposed to crack cocaine in utero.

Parcianello RR, Mardini V, Ceresér KMM, Langleben DD, Xavier F, Zavaschi MLS, Rhode LAP, Pechansky F, Gubert C, Szobot CM.

Psychopharmacology (Berl). 2018 Jan;235(1):215-222. doi: 10.1007/s00213-017-4759-6. Epub 2017 Oct 28.

PMID:
29080905
6.

Individual differences in the processing of smoking-cessation video messages: An imaging genetics study.

Shi Z, Wang AL, Aronowitz CA, Romer D, Langleben DD.

Biol Psychol. 2017 Sep;128:125-131. doi: 10.1016/j.biopsycho.2017.07.019. Epub 2017 Jul 28.

PMID:
28757070
7.

Oral glucose tolerance test performance in olanzapine-treated schizophrenia-spectrum patients is predicted by BMI and triglycerides but not olanzapine dose or duration.

Guina J, Roy S, Gupta A, Langleben DD, Elman I.

Hum Psychopharmacol. 2017 Jul;32(4). doi: 10.1002/hup.2604. Epub 2017 Jun 1.

PMID:
28573760
8.

Clinical Correlates of Oral Glucose Tolerance Test Performance in Olanzapine-Treated Patients with Schizophrenia or Schizoaffective Disorder.

Guina J, Gupta A, Langleben DD, Elman I.

J Clin Psychiatry. 2016 Dec;77(12):e1650-e1651. doi: 10.4088/JCP.16l10705. No abstract available.

9.

Polygraphy and Functional Magnetic Resonance Imaging in Lie Detection: A Controlled Blind Comparison Using the Concealed Information Test.

Langleben DD, Hakun JG, Seelig D, Wang AL, Ruparel K, Bilker WB, Gur RC.

J Clin Psychiatry. 2016 Oct;77(10):1372-1380. doi: 10.4088/JCP.15m09785.

PMID:
26794034
10.

Emotional, physical and sexual abuse are associated with a heightened limbic response to cocaine cues.

Regier PS, Monge ZA, Franklin TR, Wetherill RR, Teitelman A, Jagannathan K, Suh JJ, Wang Z, Young KA, Gawrysiak M, Langleben DD, Kampman KM, O'Brien CP, Childress AR.

Addict Biol. 2017 Nov;22(6):1768-1777. doi: 10.1111/adb.12445. Epub 2016 Sep 22.

11.

Targeting modulates audiences' brain and behavioral responses to safe sex video ads.

Wang AL, Lowen SB, Shi Z, Bissey B, Metzger DS, Langleben DD.

Soc Cogn Affect Neurosci. 2016 Oct;11(10):1650-7. doi: 10.1093/scan/nsw070. Epub 2016 May 19.

12.

Playing it safe: a video game probing the relationship between addiction, gender, and avoidance.

Shi Z, Wang AL, Langleben DD.

J Clin Psychiatry. 2016 Mar;77(3):395-7. doi: 10.4088/JCP.16com10752. No abstract available.

13.

Neural correlates of adherence to extended-release naltrexone pharmacotherapy in heroin dependence.

Wang AL, Elman I, Lowen SB, Blady SJ, Lynch KG, Hyatt JM, O'Brien CP, Langleben DD.

Transl Psychiatry. 2015 Mar 17;5:e531. doi: 10.1038/tp.2015.20.

14.

Buprenorphine-naloxone treatment of prescription opioid abuse: does past performance predict future results?

Langleben DD.

J Clin Psychiatry. 2015 Feb;76(2):195-7. doi: 10.4088/JCP.14com09617. No abstract available.

15.

Emotional reaction facilitates the brain and behavioural impact of graphic cigarette warning labels in smokers.

Wang AL, Lowen SB, Romer D, Giorno M, Langleben DD.

Tob Control. 2015 May;24(3):225-32. doi: 10.1136/tobaccocontrol-2014-051993. Epub 2015 Jan 6.

16.

Low message sensation health promotion videos are better remembered and activate areas of the brain associated with memory encoding.

Seelig D, Wang AL, Jagannathan K, Loughead JW, Blady SJ, Childress AR, Romer D, Langleben DD.

PLoS One. 2014 Nov 19;9(11):e113256. doi: 10.1371/journal.pone.0113256. eCollection 2014. Erratum in: PLoS One. 2015;10(3):e0123143. Jaganathan, Kanchana [corrected to Jagannathan, Kanchana].

17.

Focus on addiction: Buspirone for cocaine relapse and monitoring controlled substances prescribed to dually diagnosed patients.

Langleben DD.

J Clin Psychiatry. 2014 Jul;75(7):748-9. doi: 10.4088/JCP.14f09279. No abstract available.

18.

Emotional graphic cigarette warning labels reduce the electrophysiological brain response to smoking cues.

Wang AL, Romer D, Elman I, Turetsky BI, Gur RC, Langleben DD.

Addict Biol. 2015 Mar;20(2):368-76. doi: 10.1111/adb.12117. Epub 2013 Dec 15.

19.

The effect of naltrexone on body fat mass in olanzapine-treated schizophrenic or schizoaffective patients: a randomized double-blind placebo-controlled pilot study.

Taveira TH, Wu WC, Tschibelu E, Borsook D, Simonson DC, Yamamoto R, Langleben DD, Swift R, Elman I.

J Psychopharmacol. 2014 Apr;28(4):395-400. doi: 10.1177/0269881113509904. Epub 2013 Nov 11.

PMID:
24218048
20.

Brain trauma, PET scans and forensic complexity.

Moriarty JC, Langleben DD, Provenzale JM.

Behav Sci Law. 2013 Nov-Dec;31(6):702-20. doi: 10.1002/bsl.2089. Epub 2013 Oct 16.

PMID:
24132788
21.

Using Brain Imaging for Lie Detection: Where Science, Law and Research Policy Collide.

Langleben DD, Moriarty JC.

Psychol Public Policy Law. 2013 May 1;19(2):222-234.

22.

Content matters: neuroimaging investigation of brain and behavioral impact of televised anti-tobacco public service announcements.

Wang AL, Ruparel K, Loughead JW, Strasser AA, Blady SJ, Lynch KG, Romer D, Cappella JN, Lerman C, Langleben DD.

J Neurosci. 2013 Apr 24;33(17):7420-7. doi: 10.1523/JNEUROSCI.3840-12.2013.

23.

Extended-release naltrexone modulates brain response to drug cues in abstinent heroin-dependent patients.

Langleben DD, Ruparel K, Elman I, Loughead JW, Busch EL, Cornish J, Lynch KG, Nuwayser ES, Childress AR, O'Brien CP.

Addict Biol. 2014 Mar;19(2):262-71. doi: 10.1111/j.1369-1600.2012.00462.x. Epub 2012 Jul 2.

PMID:
22747521
24.

Depot naltrexone decreases rewarding properties of sugar in patients with opioid dependence.

Langleben DD, Busch EL, O'Brien CP, Elman I.

Psychopharmacology (Berl). 2012 Apr;220(3):559-64. doi: 10.1007/s00213-011-2503-1. Epub 2011 Sep 30.

25.

Emerging neurotechnologies for lie-detection: promises and perils.

Wolpe PR, Foster KR, Langleben DD.

Am J Bioeth. 2010 Oct;10(10):40-8. doi: 10.1080/15265161.2010.519238.

PMID:
20945266
26.

Gender differences in the motivational processing of babies are determined by their facial attractiveness.

Yamamoto R, Ariely D, Chi W, Langleben DD, Elman I.

PLoS One. 2009 Jun 24;4(6):e6042. doi: 10.1371/journal.pone.0006042.

27.

Reduced prefrontal and temporal processing and recall of high "sensation value" ads.

Langleben DD, Loughead JW, Ruparel K, Hakun JG, Busch-Winokur S, Holloway MB, Strasser AA, Cappella JN, Lerman C.

Neuroimage. 2009 May 15;46(1):219-25. doi: 10.1016/j.neuroimage.2008.12.062. Epub 2009 Jan 14.

28.

Baby schema modulates the brain reward system in nulliparous women.

Glocker ML, Langleben DD, Ruparel K, Loughead JW, Valdez JN, Griffin MD, Sachser N, Gur RC.

Proc Natl Acad Sci U S A. 2009 Jun 2;106(22):9115-9. doi: 10.1073/pnas.0811620106. Epub 2009 May 18.

29.

Baby Schema in Infant Faces Induces Cuteness Perception and Motivation for Caretaking in Adults.

Glocker ML, Langleben DD, Ruparel K, Loughead JW, Gur RC, Sachser N.

Ethology. 2009 Mar;115(3):257-263.

30.

Commentary: the future of forensic functional brain imaging.

Langleben DD, Dattilio FM.

J Am Acad Psychiatry Law. 2008;36(4):502-4.

PMID:
19092068
31.

Low prefrontal perfusion linked to depression symptoms in methadone-maintained opiate-dependent patients.

Suh JJ, Langleben DD, Ehrman RN, Hakun JG, Wang Z, Li Y, Busch SI, O'Brien CP, Childress AR.

Drug Alcohol Depend. 2009 Jan 1;99(1-3):11-7. doi: 10.1016/j.drugalcdep.2008.06.007. Epub 2008 Jul 31.

32.

Towards clinical trials of lie detection with fMRI.

Hakun JG, Ruparel K, Seelig D, Busch E, Loughead JW, Gur RC, Langleben DD.

Soc Neurosci. 2009;4(6):518-27. doi: 10.1080/17470910802188370.

PMID:
18633835
33.

fMRI investigation of the cognitive structure of the Concealed Information Test.

Hakun JG, Seelig D, Ruparel K, Loughead JW, Busch E, Gur RC, Langleben DD.

Neurocase. 2008;14(1):59-67. doi: 10.1080/13554790801992792.

PMID:
18569732
34.

Cocaine decreases plasma insulin concentrations in non-diabetic subjects: a randomized double-blind study.

Rott D, Langleben DD, Elman I.

Diabet Med. 2008 Apr;25(4):510-1. doi: 10.1111/j.1464-5491.2008.02412.x. Epub 2008 Mar 13. No abstract available.

PMID:
18346162
35.

Acute effect of methadone maintenance dose on brain FMRI response to heroin-related cues.

Langleben DD, Ruparel K, Elman I, Busch-Winokur S, Pratiwadi R, Loughead J, O'Brien CP, Childress AR.

Am J Psychiatry. 2008 Mar;165(3):390-4. Epub 2007 Dec 3.

PMID:
18056224
36.

Effect of methylphenidate on Stroop Color-Word task performance in children with attention deficit hyperactivity disorder.

Langleben DD, Monterosso J, Elman I, Ash B, Krikorian G, Austin G.

Psychiatry Res. 2006 Mar 30;141(3):315-20. Epub 2006 Mar 3.

PMID:
16516306
37.

Classifying spatial patterns of brain activity with machine learning methods: application to lie detection.

Davatzikos C, Ruparel K, Fan Y, Shen DG, Acharyya M, Loughead JW, Gur RC, Langleben DD.

Neuroimage. 2005 Nov 15;28(3):663-8. Epub 2005 Oct 5.

PMID:
16169252
38.

Telling truth from lie in individual subjects with fast event-related fMRI.

Langleben DD, Loughead JW, Bilker WB, Ruparel K, Childress AR, Busch SI, Gur RC.

Hum Brain Mapp. 2005 Dec;26(4):262-72.

PMID:
16161128
39.

Emerging neurotechnologies for lie-detection: promises and perils.

Wolpe PR, Foster KR, Langleben DD.

Am J Bioeth. 2005 Spring;5(2):39-49.

PMID:
16036700
40.

Neural substrates for functionally discriminating self-face from personally familiar faces.

Platek SM, Loughead JW, Gur RC, Busch S, Ruparel K, Phend N, Panyavin IS, Langleben DD.

Hum Brain Mapp. 2006 Feb;27(2):91-8.

PMID:
16035037
41.

Magnetic resonance detects brainstem changes in chronic, active heavy drinkers.

Bloomer CW, Langleben DD, Meyerhoff DJ.

Psychiatry Res. 2004 Dec 30;132(3):209-18.

PMID:
15664792
42.

Effects of pharmacological doses of 2-deoxyglucose on plasma catecholamines and glucose levels in patients with schizophrenia.

Elman I, Rott D, Green AI, Langleben DD, Lukas SE, Goldstein DS, Breier A.

Psychopharmacology (Berl). 2004 Nov;176(3-4):369-75. Epub 2004 Jun 4.

PMID:
15179540
43.

The acute effect of methylphenidate on cerebral blood flow in boys with attention-deficit/hyperactivity disorder.

Szobot CM, Ketzer C, Cunha RD, Parente MA, Langleben DD, Acton PD, Kapczinski F, Rohde LA.

Eur J Nucl Med Mol Imaging. 2003 Mar;30(3):423-6. Epub 2003 Jan 11.

PMID:
12634972
44.

Effects of methylphenidate discontinuation on cerebral blood flow in prepubescent boys with attention deficit hyperactivity disorder.

Langleben DD, Acton PD, Austin G, Elman I, Krikorian G, Monterosso JR, Portnoy O, Ridlehuber HW, Strauss HW.

J Nucl Med. 2002 Dec;43(12):1624-9.

45.

Brain activity during simulated deception: an event-related functional magnetic resonance study.

Langleben DD, Schroeder L, Maldjian JA, Gur RC, McDonald S, Ragland JD, O'Brien CP, Childress AR.

Neuroimage. 2002 Mar;15(3):727-32.

PMID:
11848716
46.

Interhemispheric asymmetry of regional cerebral blood flow in prepubescent boys with attention deficit hyperactivity disorder.

Langleben DD, Austin G, Krikorian G, Ridlehuber HW, Goris ML, Strauss HW.

Nucl Med Commun. 2001 Dec;22(12):1333-40.

PMID:
11711904
47.

PET in differentiation of recurrent brain tumor from radiation injury.

Langleben DD, Segall GM.

J Nucl Med. 2000 Nov;41(11):1861-7. Review.

Supplemental Content

Loading ...
Support Center